EIGHT YEARS OF DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST FIVE YEARS OF THE FREEDOM EXTENSION

被引：0

作者：

Papapoulos, S. ^{[1
]}

Lippuner, K. ^{[2
]}

Roux, C. ^{[3
]}

Lin, C. J. F. ^{[4
]}

Kendler, D. L. ^{[5
]}

Lewiecki, E. M. ^{[6
]}

Brandi, M. L. ^{[7
]}

Czerwinski, E. ^{[8
]}

Franek, E. ^{[9
]}

Lakatos, P. L. ^{[10
]}

Mautalen, C. ^{[11
]}

Minisola, S. ^{[12
]}

Reginster, J-Y ^{[13
]}

Jensen, S. ^{[14
]}

Daizadeh, N.

Wang, A.

Gavin, M.

Wagman, R. B.

Bone, H. G. ^{[15
]}

机构：

[1] Leiden Univ, Med Ctr, Leiden, Netherlands

[2] Univ Hosp Bern, CH-3010 Bern, Switzerland

[3] Paris Descartes Univ, Paris, France

[4] Amgen Inc, Thousand Oaks, CA 91320 USA

[5] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada

[6] New Mexico Clin Res & Osteoporosis Ctr, Albuquerque, NM USA

[7] Univ Florence, Florence, Italy

[8] Krakow Med Ctr, Krakow, Poland

[9] Cent Clin Hosp MSWiA, Warsaw, Poland

[10] Semmelweis Univ, H-1085 Budapest, Hungary

[11] Ctr Osteopatias Med, Buenos Aires, DF, Argentina

[12] Univ Roma La Sapienza, I-00185 Rome, Italy

[13] Univ Liege, Liege, Belgium

[14] CCBR, Ballerup, Denmark

[15] Michigan Bone & Mineral Clin, Detroit, MI USA

来源：

OSTEOPOROSIS INTERNATIONAL | 2014年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OC21

引用

页码：S118 / S119

页数：2

共 50 条

[21] The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension
Bone, Henry G.
Chapurlat, Roland
Brandi, Maria-Luisa
Brown, Jacques P.
Czerwinski, Edward
Krieg, Marc-Antoine
Mellstrom, Dan
Radominski, Sebastiao C.
Reginster, Jean-Yves
Resch, Heinrich
Roman Ivorra, Jose A.
Roux, Christian
Vittinghoff, Eric
Daizadeh, Nadia S.
Wang, Andrea
Bradley, Michelle N.
Franchimont, Nathalie
Geller, Michelle L.
Wagman, Rachel B.
Cummings, Steven R.
Papapoulos, Socrates
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (11): : 4483 - 4492
[22] DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS FOR UP TO 9 YEARS: RESULTS THROUGH YEAR 6 OF THE FREEDOM EXTENSION
Papapoulos, S.
Roux, C.
Bone, H. G.
Dakin, P.
Czerwinski, E.
Frey, D.
Kendler, D.
Lewiecki, E. M.
Malouf, J.
Mellstrom, D.
Reginster, J. -Y.
Resch, H.
Daizadeh, N. S.
Wang, A.
Gavin, M.
Wagman, R. B.
Brandi, M. L.
[J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S37 - S39
[23] DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS FOR UP TO 9 YEARS: RESULTS THROUGH YEAR 6 OF THE FREEDOM EXTENSION
Papapoulos, S.
Roux, C.
Bone, H. G.
Dakin, P.
Czerwinski, E.
Frey, D.
Kendler, D.
Lewiecki, E. M.
Malouf, J.
Mellstrom, D.
Reginster, J. Y.
Resch, H.
Daizadeh, N. S.
Wang, A.
Gavin, M.
Wagman, R. B.
Brandi, M. L.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 529 - 530
[24] 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
Bone, Henry G.
Wagman, Rachel B.
Brandi, Maria L.
Brown, Jacques P.
Chapurlat, Roland
Cummings, Steven R.
Czerwinski, Edward
Fahrleitner-Pammer, Astrid
Kendler, David L.
Lippuner, Kurt
Reginster, Jean-Yves
Roux, Christian
Malouf, Jorge
Bradley, Michelle N.
Daizadeh, Nadia S.
Wang, Andrea
Dakin, Paula
Pannacciulli, Nicola
Dempster, David W.
Papapoulos, Socrates
[J]. LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (07): : 513 - 523
[25] Effect of Denosumab Treatment in Postmenopausal Women with Osteoporosis: Eight-Year Results from the Freedom Extension, Phase 3 Clinical Trial
Lewiecki, E. Michael
Papapoulos, Socrates
Lippuner, Kurt
Roux, Christian
Lin, Celia J. F.
Kendler, David L.
Brandi, Maria L.
Czerwinski, Edward
Franek, Edward
Lakatos, Peter
Minisola, Salvatore
Reginster, Jean-Yves
Jensen, Soren
Daizadeh, Nadia
Wang, Andrea
Gavin, Mary
Wagman, Rachel B.
Bone, Henry G.
[J]. ENDOCRINE REVIEWS, 2014, 35 (03)
[26] Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension
Ferrari, Serge
Eastell, Richard
Napoli, Nicola
Schwartz, Ann
Hofbauer, Lorenz C.
Chines, Arkadi
Wang, Andrea
Pannacciulli, Nico
Cummings, Steven R.
[J]. BONE, 2020, 134
[27] Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing Results from the FREEDOM Trial
Adami, Silvano
Libanati, Cesar
Boonen, Steven
Cummings, Steven R.
Ho, Pei-Ran
Wang, Andrea
Siris, Ethel
Lane, Joseph
[J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2012, 94A (23): : 2113 - 2119
[28] Evaluation of Invasive Oral Procedures and Events in Women With Postmenopausal Osteoporosis Treated for up to 10 Years With Denosumab: Results From the Phase 3 FREEDOM Open-label Extension.
Watts, Nelson B.
Butler, Peter W.
Binkley, Neil
Grbic, John T.
McClung, Michael
Tierney, Antoniette
Wagman, Rachel B.
Yin, Xiang
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S5 - S5
[29] DENOSUMAB REDUCED OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS WITH PRIOR FRACTURE: RESULTS FROM FREEDOM
Palacios, Santiago
Rizzoli, R.
Zapalowski, C.
Resch, H.
Adami, S.
Adachi, J. D.
Gallagher, J. C.
Feldman, R. G.
Kendler, D. L.
El-Haschimi, K.
Wang, A.
Wagman, R. B.
Boonen, S.
[J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S299 - S300
[30] DENOSUMAB (DMAB) TREATMENT FOR 6 YEARS MAINTAINS LOW FRACTURE INCIDENCE IN WOMEN ≥75 YEARS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO)
Papapoulos, Socrates
Mcclung, Michael R.
Franchimont, Nathalie
Adachi, Jonathan D.
Bone, Henry G.
Benhamou, Claude-Laurent
Farrerons, Jordi
Gallagher, John Christopher
Halse, Johan
Lippuner, Kurt
Man, Zulema
Minisola, Salvatore
Torring, Ove
Daizadeh, Nadia
Wang, Andrea
Wagman, Rachel B.
Boonen, Steven
[J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S45 - S46

← 1 2 3 4 5 →